XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Note 15 - Share-based Compensation
9 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 15.  Share-Based Compensation

Equity Plans

The Company’s board of directors and stockholders approved the following equity plans:

 

the 2021 Equity Incentive Plan ("2021 Plan")

 the 2023 Equity Inducement Plan ("Inducement Plan")

 

The Company has issued stock options, restricted stock awards ("RSAs") and restricted stock units ("RSUs") to employees, consultants and non-employee directors. Stock option awards generally vest over a four-year period and have a maximum term of ten years. Stock options under these plans have been granted with an exercise price equal to the fair market value on the date of the grant. Nonqualified and Incentive Stock Options, RSAs and RSUs may be granted from these plans.

Performance Based Incentive Plan

 

Starting in 2021, certain senior executives were granted performance stock units ("PSUs") under our Amended and Restated 2021 Equity Incentive Plan ("2021 Plan"), which generally vest over a three-year period subject to achievement of certain pre-established performance metrics. The number of shares of common stock that would ultimately be issued to settle PSUs granted ranged from 0% to 200% of the target number of shares granted. We estimate the fair value of the PSUs on the date of grant using a Monte Carlo simulation model, with stock-based compensation expense recognized ratably over the applicable three-year performance period. The Company recognized stock-based compensation expense for the PSUs for the three months ended  September 30, 2025 and 2024 of $1.2 million and $3.8 million, respectively. The Company recognized stock-based compensation expense for the PSUs for the nine months ended  September 30, 2025 and 2024 of $3.3 million and $5.8 million, respectively. 

 

The following is a summary of PSU activity for the nine months ended September 30, 2025:

 

      Weighted         
     

Average

  

Weighted

  

Aggregate

 
  

Number of

  

Exercise

  

Average

  

Intrinsic

 
  

shares

  

Price

  

Fair Value

  

Value

 
  

(in thousands, except price data and Contractual Life)

 

Outstanding at January 1, 2025

  1,447     $7.72  $53,347 

Granted

  719      6.94   8,851 

Exercised

  (978) $14.76   2.48   14,431 

Forfeited

            

Outstanding, September 30, 2025

  1,189      11.55   30,541 

Vested and expected to vest

  1,189     $11.55  $30,541 

 

As of September 30, 2025, there was $6.2 million of unrecognized stock-based compensation expense related to outstanding PSUs, which expense is expected to be recognized over 1.9 years.

 

Restricted Stock Units

 

The following is a summary of RSU activity:

 

     

Weighted

       
     

Average Share

  

Weighted

  

Aggregate

 
  

Number of

  

Price on Date

  

Average Fair

  

Intrinsic

 
  

shares

  

of Release

  

Value

  

Value

 
  

(in thousands, except price data)

 

Outstanding, January 1, 2025

  2,231     $6.04  $82,243 

Granted

  489      12.38   6,055 

Released

  (940) $6.22   22.59   21 

Cancelled/Forfeited

  (40)     5.91   1,040 

Outstanding, September 30, 2025

  1,074      7.73   45,124 

Vested and expected to vest

  1,074     $7.73  $45,124 

As of September 30, 2025, there was $12.1 million of unrecognized compensation expense related to these RSUs. This expense is expected to be recognized over 2.3 years.

 

Share-Based Compensation

Employee share-based compensation expenses recognized for the periods indicated (in thousands):

  

Three months ended

  

Nine months ended

 
  

September 30,

  

September 30,

 
  

2025

  

2024

  

2025

  

2024

 

Share-based compensation - by expense types

            

Cost of goods sold

 $87  $116  $264  $355 

Research and development

  293   356   900   1,114 

Sales and marketing

  275   334   1,097   1,160 

General and administrative

  2,460   2,137   6,580   9,212 

Total share-based compensation expense

 $3,116  $2,943  $8,842  $11,841